Studies

A-HeFT

A-PLUS

AALL1731

AATAC

ABC-Sepsis

ABYSS

ACCOMPLISH

ACCORD

ACCORD BP

ACCORD Lipid

ACE-PROTAVI

ACES

ACORN

ACOSOG Z0011 (10-year survival)

ACOSOG Z0011 (5-year survival)

ACT

ACT HIV

ACTFAST-3

ACTIV-3-TICO

ACTIV-4A (P2Y12 inhibitor plus heparin)

ACTIV-4a (SGLT2 inhibitors)

ACTIV-4C

ACTIV-6 (fluvoxamine)

ACTIV-6 (ivermectin)

ACTIV-6 (montelukast)

ACTIVE A

ACTIVE W

ACTT-1

ACTT-4

ACURASYS

ADAPT

ADAPT-PO

ADAPT-Sepsis (CRP-guided)

ADAPT-Sepsis (procalcitonin-guided)

ADAPT-TAVR

ADAURA

ADH-Wizard

ADIGE

Adjuvant Chemotherapy for High-Risk Retinoblastoma

Adjuvant HAIC with FOLFOX for HCC

ADMINISTER

ADRENAL

ADRIATIC

ADVANCE (apixaban)

ADVANCE (intensive glucose control)

ADVANCE-CIDP 1

ADVOCATE

ADVOR

AECOPD

AEGEAN

AF-CHF

AFFINITY

AFFIRM

Age Trial

AGENT IDE

AHA STEROID

AID-ICU

AIDA

AiDAPT

AIRFLO

AIRTRIP

AIRWAY-2

AKIKI

ALBIOS

Albumin for CSA-AKI

Albumin for SBP

Alendronate for osteoporosis in men

Alendronate Phase III Osteoporosis Treatment Study

ALEX

ALEXANDRA/IMpassion030

ALIGN

ALL-HEART

ALLEGRO

ALLHAT (angiotensin-converting enzyme inhibitor)

ALLHAT (calcium channel blocker)

Alliance A011502

ALLIUM

ALMS

ALPS (follow-up)

Alternate day vs. daily oral iron in IDA

ALTITUDE

AMACING

AMAZES

AMBASSADOR

AMBITION-CM

AMBROISIE

AMETIS

AMIKINHAL

AMPLIFY (acalabrutinib/venetoclax)

AMPLIFY (acalabrutinib/venetoclax/obinutuzumab)

AMPLIFY (apixaban)

AMPLIFY-EXT (apixaban 2.5 mg)

AMPLIFY-EXT (apixaban 5 mg)

ANAHYDRET

ANCHOR

ANDROMEDA

ANDROMEDA-SHOCK

ANGEL-ASPECT

Annane Trial

ANNEXA-I

ANRS 174 DOXYVAC (4CMenB vaccine)

ANRS 174 DOXYVAC (doxycycline PEP)

ANRS IPERGAY

ANSWER

ANT-005 TKA (mid-dose)

Anterior Gastropexy for MIS-PEHR

ANTHARTIC

AntibioCor

ANTICIPUSC

Antimicrobial prophylaxis in pancreatoduodenectomy

APEX

API-CAT

APPIC

APPLAUSE-IgAN

APROCCHSS

APTS

APW-RSV-II

AQCS-Assisted Colonoscopy

AQUILA

ARAIS

ARAMIS

ARASENS

ARBs CORONA II

ARCADIA (original research)

ARCADIA (post-hoc analysis)

ARCADIA-MRI

ARDSNet

AREDS2

ARES (aspirin BID vs. aspirin OD)

ARES (aspirin TID vs. aspirin OD)

AReSVi-006

ARIES-HM3 (original research)

ARIES-HM3 (secondary analysis)

ARISE

ARISTOTLE

ARIVA

ARREST

ARRIVE (aspirin)

ARRIVE (labor induction)

ART

Artemisinin Combination for Postpartum Malaria

ARTESIA

ARUBA

ASC4FIRST

ASCEMBL

ASCEND (aspirin)

ASCEND (pirfenidone)

ASCEND-D

ASPIRE

ASPRE

ASPREE

ASPREE (secondary analysis)

ASPREE-Hearing

ASSIT

ASTRAL

ATACH II

ATAMIS

ATESS

ATHOS-3

ATLAS (cabotegravir and rilpivirine)

ATLAS (tamoxifen)

ATLAS ACS 2-TIMI 51 (rivaroxaban 10 mg)

ATLAS ACS 2-TIMI 51 (rivaroxaban 5 mg)

ATLAS-2M (152-week results)

ATLAS-2M (48-week results)

ATN

ATTENTION-IA

ATTIRE

ATTKPATRASCOVID19

ATTR-ACT

ATTRACT

ATTRibute-CM

AUGUSTUS (anticoagulation regimen)

AUGUSTUS (antiplatelet regimen)

AURORA (maribavir)

AURORA (rosuvastatin)

AURORA 2

AUSTRI

Autologous Serum in DES

AVATAR

AVB-TIPS

AVENIR (children)

AVENIR (infants)

AVERROES

AVERT

AVERT (subgroup analysis)

AVERT Shock

AVOID

AWARE

AXIOMATIC-TKR (high-dose)

AZA-001

AZALEA-TIMI 71 (high-dose abelacimab)

AZALEA-TIMI 71 (low-dose abelacimab)

AZT Trial